The divergence of signalling for EMP regulation between EGF and hypoxia that we characterise here is of therapeutic importance, particularly bearing in mind associations in breast cancer patients between EMT, poor prognosis and treatment resistance. The gene discussed is EGF; the disease is breast cancer.